Monkey NEFL (Neurofilament, Light Polypeptide) ELISA Kit
- Known as:
- Monkey NEFL (Neurofilament, Light Polypeptide) Enzyme-linked immunosorbent assay test Kit
- Catalog number:
- e-el-mk1892
- Product Quantity:
- USD
- Category:
- -
- Supplier:
- Elabscience
- Gene target:
- Monkey NEFL (Neurofilament Light Polypeptide) ELISA Kit
Related genes to: Monkey NEFL (Neurofilament, Light Polypeptide) ELISA Kit
- Gene:
- NEFL NIH gene
- Name:
- neurofilament light
- Previous symbol:
- -
- Synonyms:
- NFL, CMT1F, CMT2E, NF68, PPP1R110
- Chromosome:
- 8p21.2
- Locus Type:
- gene with protein product
- Date approved:
- 2001-06-22
- Date modifiied:
- 2019-04-23
Related products to: Monkey NEFL (Neurofilament, Light Polypeptide) ELISA Kit
Related articles to: Monkey NEFL (Neurofilament, Light Polypeptide) ELISA Kit
- Prion diseases can mimic Alzheimer disease (AD) at presentation. Alzheimer's Association AD diagnostic criteria suggest that a single abnormal highly specific plasma biomarker (including p-tau217) is sufficient for a biological diagnosis. We investigated the performance of AD plasma biomarkers in distinguishing AD and prion diseases. - Source: PubMed
Publication date: 2026/07/13
Coysh ThomasLaban RhiannonVeleva ElenaHeslegrave Amanda JDarwent LeeHolm-Mercer LeahMok Tze HowHart Melanie SarahLunn Michael PeterKeshavan AshviniSchott Jonathan MJaunmuktane ZaneBrandner SebastianGonzalez-Ortiz FernandoBlennow KajZetterberg HenrikCollinge JohnMead Simon - Plasma neurofilament light chain (pNfL) is a blood-based biomarker of axonal injury elevated in several neuromuscular disorders. While previous studies have compared individual diseases with healthy controls, less is known about how pNfL performs across clinically relevant neuromuscular presentations encountered in subspecialty practice, particularly in distinguishing active from inactive neuropathies. We evaluated whether abnormal age-adjusted pNfL concentrations are associated with clinically relevant diagnostic categories and whether pNfL discriminates between active and inactive neuropathies. - Source: PubMed
Publication date: 2026/07/13
Schipani Elke SJones Felipe J SStaff Nathan PBornhorst Joshua ASorenson Eric JDubey DivyanshuPinto Marcus VMauermann Michelle L - Biomarkers reflecting the complex pathophysiology of genetic frontotemporal dementia (FTD) will be increasingly important with the advent of therapeutic trials aiming to slow or prevent the disease. In this study, we aimed to identify blood biomarker candidates using a multiplex panel of CNS-related proteins. - Source: PubMed
Simrén JoelBenedet Andrea LDi Molfetta GuglielmoPola IlariaTan KübraCantoni ValentinaLibri IleniaRivolta JasmineGhidoni RobertaZetterberg HenrikBorroni BarbaraAshton Nicholas J - Blood-based biomarkers are increasingly recognized as promising tools for the diagnosis and monitoring of neurodegenerative diseases, offering a minimally invasive alternative to cerebrospinal fluid (CSF) testing. We evaluated the analytical performance and clinical utility of the Olink Target 48 Neurodegeneration panel, a novel multiplex proteomic platform based on the proximity extension assay (PEA) technology, in a large, clinically diverse dementia cohort. - Source: PubMed
Publication date: 2026/07/11
Bentivenga Giuseppe MarioMammana AngelaBaiardi SimoneVittoriosi EricaMastrangelo AndreaRuggeri EdoardoVargiu Claudia MarinaPolischi BarbaraStanzani-Maserati MichelangeloRizzo GiovanniPantieri RobertaRaggi AlbertoCapellari SabinaParchi Piero - Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) are promising multiple sclerosis (MS) biomarkers, but biological confounding and inter-assay variability limit real-world use. We assessed whether Z score normalisation enables platform-agnostic monitoring in people with MS (pwMS) under ocrelizumab, and which early timepoint best stratifies subsequent biomarker trajectories. - Source: PubMed
Publication date: 2026/07/10
Inojosa HernanMasanneck LarsAkgün KatjaHagler RamonaMeuth Sven GOtto CarolinSchindler PatrickSchulze-Bosse KarinKuhle JensBenkert PascalRuprecht KlemensPawlitzki MarcZiemssen Tjalf